|Articles|July 20, 2022
mRNA 5’ cap characterization using LC-HRAM-MS
Author(s)Thermo Fisher Scientific
The 5’ capping is a CQA for mRNA vaccines and therapeutics, and needs to be fully characterized. Learn a sensitive, robust LC-HRAM-MS/MS method for identification and quantitation of 5’ cap.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Formulation Strategies, Tech Advances, Challenges, and Considerations in Novel Drug Delivery
2
Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture
3
How New ADC Modalities Backed by Samsung Could Shape Solid Tumor Treatment
4
What a $2 Billion Maryland Expansion Means for the Future of Biologics Production
5
